AT282824B - Verfahren zur Herstellung einer neuen Adjuvansvaccine - Google Patents

Verfahren zur Herstellung einer neuen Adjuvansvaccine

Info

Publication number
AT282824B
AT282824B AT1092168A AT1092168A AT282824B AT 282824 B AT282824 B AT 282824B AT 1092168 A AT1092168 A AT 1092168A AT 1092168 A AT1092168 A AT 1092168A AT 282824 B AT282824 B AT 282824B
Authority
AT
Austria
Prior art keywords
preparation
adjuvant vaccine
new adjuvant
new
vaccine
Prior art date
Application number
AT1092168A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of AT282824B publication Critical patent/AT282824B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT1092168A 1967-11-13 1968-11-11 Verfahren zur Herstellung einer neuen Adjuvansvaccine AT282824B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51507/67A GB1163470A (en) 1967-11-13 1967-11-13 Improvements in or relating to Adjuvant Vaccines

Publications (1)

Publication Number Publication Date
AT282824B true AT282824B (de) 1970-07-10

Family

ID=10460292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1092168A AT282824B (de) 1967-11-13 1968-11-11 Verfahren zur Herstellung einer neuen Adjuvansvaccine

Country Status (9)

Country Link
US (1) US3594471A (de)
AT (1) AT282824B (de)
BE (1) BE723727A (de)
DE (1) DE1807820A1 (de)
DK (1) DK121454B (de)
ES (1) ES360080A1 (de)
FR (1) FR8174M (de)
GB (1) GB1163470A (de)
NL (1) NL6816071A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
US4258029A (en) * 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
CA1202903A (en) * 1982-04-29 1986-04-08 Edgar E. Ribi Stable composition and preparation thereof
US4600583A (en) * 1982-09-07 1986-07-15 Tetra Consultants Inc. Pharmaceutical compositions
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
US4556556A (en) * 1984-03-23 1985-12-03 Advanced Genetics Research Institute Vaccine for the prevention of vesicular stomatitis virus infection
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
CN1607941A (zh) * 2001-11-19 2005-04-20 贝克顿迪肯森公司 粒状药物组合物
US20060062807A1 (en) * 2001-12-11 2006-03-23 Marie-Anne Nahori Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Also Published As

Publication number Publication date
US3594471A (en) 1971-07-20
BE723727A (de) 1969-05-12
NL6816071A (de) 1969-05-16
DE1807820A1 (de) 1969-08-07
DK121454B (da) 1971-10-18
ES360080A1 (es) 1970-10-01
FR8174M (de) 1970-08-31
GB1163470A (en) 1969-09-04

Similar Documents

Publication Publication Date Title
CH488705A (de) Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
AT291926B (de) Verfahren zur Herstellung einer Bindemittelsuspension
AT287196B (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Mastitis
AT282824B (de) Verfahren zur Herstellung einer neuen Adjuvansvaccine
CH472368A (de) Verfahren zur Herstellung eines sekundären Aralkylamins
CH464957A (de) Verfahren zur Herstellung eines neuen Glucosids
AT284605B (de) Verfahren zur Herstellung einer Gelierhilfe
CH469093A (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
CH543480A (de) Verfahren zur Herstellung von neuen Aminoketonen II
AT282821B (de) Verfahren zur Herstellung einer antigenfreien Vaccine
CH504395A (de) Verfahren zur Herstellung einer Hydroxyindanverbindung
CH437302A (de) Verfahren zur Herstellung einer neuen Dibenzocycloheptanverbindung
AT273636B (de) Verfahren zur Herstellung eines Präparates mit Fleischgeschmack
AT285044B (de) Verfahren zur Herstellung einer somatischen Antigenvaccine
AT286293B (de) Verfahren zur Herstellung von neuen Styrylthiazoliumsalzen
AT265517B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
AT286497B (de) Verfahren zur Herstellung einer Vaccine
CH482684A (de) Verfahren zur Herstellung eines neuen Herbicids
AT282603B (de) Verfahren zur Herstellung von Hydroxybenzonitrilen
AT281007B (de) Verfahren zur Herstellung von Hydroxybenzonitrilen
CH424794A (de) Verfahren zur Herstellung einer neuen kristallinen Form einer Bis-triazinylamino-stilbenverbindung
AT298681B (de) Verfahren zur Herstellung eines neuen Glucosids
AT279038B (de) Verfahren zur Herstellung eines Impfstoffes gegen Röteln
AT311385B (de) Verfahren zur Herstellung einer Katalysatorzusammensetzung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee